Literature DB >> 15772224

The natural history of left ventricular systolic function in Anderson-Fabry disease.

J S Shah, P Lee, D Hughes, R Thaman, B Sachdev, D Pellerin, A Mehta, P M Elliott.   

Abstract

Mesh：

Year:  2005        PMID： 15772224      PMCID： PMC1768858          DOI： 10.1136/hrt.2004.035584

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study.

Authors:  Frank Weidemann; Frank Breunig; Meinrad Beer; Joern Sandstede; Oliver Turschner; Wolfram Voelker; Georg Ertl; Anita Knoll; Christoph Wanner; Jörg M Strotmann
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

2.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

3.  Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.

Authors:  M Elleder; V Bradová; F Smíd; M Budĕsínský; K Harzer; B Kustermann-Kuhn; J Ledvinová; V Král; V Dorazilová
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

Authors:  James C C Moon; Bhavesh Sachdev; Andrew G Elkington; William J McKenna; Atul Mehta; Dudley J Pennell; Philip J Leed; Perry M Elliott
Journal:  Eur Heart J       Date:  2003-12       Impact factor: 29.983
  4 in total
  7 in total

Review 1.  Microvascular dysfunction in infiltrative cardiomyopathies.

Authors:  Ornella Rimoldi; Francesco Maranta
Journal:  J Nucl Cardiol       Date:  2017-07-11       Impact factor: 5.952

Review 2.  Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages.

Authors:  Saskia M Rombach; Bouwien E Smid; Gabor E Linthorst; Marcel G W Dijkgraaf; Carla E M Hollak
Journal:  J Inherit Metab Dis       Date:  2014-02-04       Impact factor: 4.982

3.  Extracellular matrix turnover and disease severity in Anderson-Fabry disease.

Authors:  J S Shah; D A Hughes; M H Tayebjee; R J MacFadyen; A B Mehta; P M Elliott
Journal:  J Inherit Metab Dis       Date:  2006-12-11       Impact factor: 4.982

4.  Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A.

Authors:  P M Elliott; H Kindler; J S Shah; B Sachdev; O E Rimoldi; R Thaman; M T Tome; W J McKenna; P Lee; P G Camici
Journal:  Heart       Date:  2005-08-05       Impact factor: 5.994

Review 5.  Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy.

Authors:  R P Morrissey; K J Philip; E R Schwarz
Journal:  Cardiovasc J Afr       Date:  2011 Jan-Feb       Impact factor: 1.167

Review 6.  Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future.

Authors:  Roberta Esposito; Ciro Santoro; Giulia Elena Mandoli; Vittoria Cuomo; Regina Sorrentino; Lucia La Mura; Maria Concetta Pastore; Francesco Bandera; Flavio D'Ascenzi; Alessandro Malagoli; Giovanni Benfari; Antonello D'Andrea; Matteo Cameli
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

Review 7.  Anderson-Fabry disease in heart failure.

Authors:  M M Akhtar; P M Elliott
Journal:  Biophys Rev       Date:  2018-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.